Literature DB >> 2686727

Human immunodeficiency virus glycoproteins: lectin binding properties.

L Hammar1, S Eriksson, B Morein.   

Abstract

Recombinant glycoproteins derived from the HIV env gene are available and are under evaluation as antigens in vaccines against AIDS. The importance of the glycoconjugate structure for eliciting a protective immune response by these proteins is incompletely known. In this report we devise a method for the characterization of the glycoconjugate and demonstrate gross differences in the composition of the carbohydrate moiety in glycoproteins derived from the HIV env gene when expressed in different cell lines.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2686727     DOI： 10.1089/aid.1989.5.495

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN： 0889-2229            Impact factor:   2.205


  7 in total

1.  Alpha-(1-3)- and alpha-(1-6)-D-mannose-specific plant lectins are markedly inhibitory to human immunodeficiency virus and cytomegalovirus infections in vitro.

Authors:  J Balzarini; D Schols; J Neyts; E Van Damme; W Peumans; E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

2.  Characterization of purified gp 51 from bovine leukemia virus integrated into iscom. Physicochemical properties and serum antibody response to the integrated gp51.

Authors:  M Merza; J Söber; B Sundquist; I Toots; B Morein
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

3.  Mannose-specific plant lectins from the Amaryllidaceae family qualify as efficient microbicides for prevention of human immunodeficiency virus infection.

Authors:  Jan Balzarini; Sigrid Hatse; Kurt Vermeire; Katrien Princen; Stefano Aquaro; Carlo-Federico Perno; Erik De Clercq; Herman Egberink; Guy Vanden Mooter; Willy Peumans; Els Van Damme; Dominique Schols
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

4.  Human immunodeficiency virus type 1 envelope glycoprotein is modified by O-linked oligosaccharides.

Authors:  H B Bernstein; S P Tucker; E Hunter; J S Schutzbach; R W Compans
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

5.  Inhibition of human immunodeficiency virus-1 infection by human conglutinin-like protein: in vitro studies.

Authors:  H Ushijima; H C Schröder; S Poznanovic; M J Gasić; E Matthes; W E Müller
Journal:  Jpn J Cancer Res       Date:  1992-05

Review 6.  A Brief Overview of Potential Treatments for Viral Diseases Using Natural Plant Compounds: The Case of SARS-Cov.

Authors:  Rambod Abiri; Hazandy Abdul-Hamid; Oksana Sytar; Ramin Abiri; Eduardo Bezerra de Almeida; Surender K Sharma; Victor P Bulgakov; Randolph R J Arroo; Sonia Malik
Journal:  Molecules       Date:  2021-06-24       Impact factor: 4.411

7.  Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle.

Authors:  Els Keyaerts; Leen Vijgen; Christophe Pannecouque; Els Van Damme; Willy Peumans; Herman Egberink; Jan Balzarini; Marc Van Ranst
Journal:  Antiviral Res       Date:  2007-03-30       Impact factor: 5.970
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.